Finance

Beta
Lists
LPCN:NASDAQ
Lipocine Inc
$2.05
-7.24%
(-0.16) 1D
$2.14
+4.39% (+0.090)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LPCN...
Open
$2.20
High
$2.20
Low
$2.05
Mkt. cap
16.90M
Avg. vol.
109.54K
Volume
87.61K
52-wk high
$12.37
52-wk low
$1.81
EPS
-$1.96
Beta
0.48
Shares outstanding
8.24M
No. of employees
14
Open
$2.20
High
$2.20
Low
$2.05
Mkt. cap
16.90M
Avg. vol.
109.54K
Volume
87.61K
52-wk high
$12.37
52-wk low
$1.81
EPS
-$1.96
Beta
0.48
Shares outstanding
8.24M
No. of employees
14
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to LPCN in the past 3 months
Buy
Buy
1
Hold
1
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for LPCN in the last 3 months.
Highest
Current $2.05
$6.00 (+192.68%)
Average
$6.00 (+192.68%)
Lowest
$6.00 (+192.68%)
News stories
From sources across the web
About Lipocine Inc
CEO-
Employees14
Founded1997
HeadquartersSalt Lake City, Utah, United States
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
622.85K
114.57K
1.15M
119.40K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.14M
2.71M
2.68M
2.76M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
890.43K
767.84K
983.39K
1.20M
Operating expense
3.03M
3.48M
3.66M
3.97M
Total operating expenses
3.03M
3.48M
3.66M
3.97M
Operating income
-2.40M
-3.36M
-2.52M
-3.85M
Other non operating income
-
-
-
-
EBT including unusual items
-2.21M
-3.19M
-2.37M
-3.67M
EBT excluding unusual items
-2.21M
-3.19M
-2.37M
-3.67M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.21M
-3.19M
-2.37M
-3.67M
Net profit margin
-354.13%
-2,781.46%
-206.92%
-3,075.37%
Earnings per share
-
-
-
-
Interest and investment income
198.64K
174.21K
145.72K
177.57K
Interest expense
-
-
-
-
Net interest expenses
198.64K
174.21K
145.72K
177.57K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.39M
-3.35M
-2.50M
-3.83M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more